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Understanding how antibiotics inhibit bacteria can help to reduce antibiotic use and hence avoid
antimicrobial resistance – yet few theoretical models exist for bacterial growth inhibition by a
clinically relevant antibiotic treatment regimen. In particular, in the clinic, antibiotic treatment is
time dependent. Here, we use a recently-developed model to obtain predictions for the dynamical
response of a bacterial cell to a time-dependent dose of ribosome-targeting antibiotic. Our results
depend strongly on whether the antibiotic shows reversible transport and/or low-affinity ribosome
binding (“low-affinity antibiotic”) or, in contrast, irreversible transport and/or high affinity ribosome
binding (“high-affinity antibiotic”). For low-affinity antibiotics, our model predicts that growth
inhibition depends on the duration of the antibiotic pulse, with a transient period of very fast
growth following removal of the antibiotic. For high-affinity antibiotics, growth inhibition depends
on peak dosage rather than dose duration, and the model predicts a pronounced post-antibiotic
effect, due to hysteresis, in which growth can be suppressed for long times after the antibiotic dose
has ended. These predictions are experimentally testable and may be of clinical significance.
I. INTRODUCTION
Modern clinical practice relies on the use of antibiotics to combat bacterial infections, yet our knowledge of
how antibiotics inhibit bacteria is surprisingly incomplete. In particular, even though the molecular processes that
are targeted by antibiotics are generally known [1], mathematical models for bacterial growth rate as a function
of antibiotic concentration are generally lacking. Development of such models can help to combat antimicrobial
resistance, because they are a crucial input for the optimisation of dosing regimes [2, 3], and also for models of
how bacteria evolve resistance to antibiotics [4–7]. In recent work, models have been proposed that can predict
the steady-state response of bacterial growth to a fixed antibiotic concentration [3, 7–9]. In the clinic, however,
the antibiotic concentration to which an infection is exposed is time-varying. In this paper, we present theoretical
predictions for the dynamical changes in bacterial growth rate in response to a time-varying concentration of a
ribosome-targeting antibiotic. Our analysis predicts qualitative, and potentially clinically relevant, differences in
the dynamical response of bacterial growth to antibiotic treatment, depending on the molecular parameters for
antibiotic-ribosome binding and transport of antibiotic across the bacterial cell boundary.
Measurements of bacterial growth inhibition by antibiotics often focus on exponentially growing bacterial pop-
ulations, whose population dynamics can be described by N(t) ∼ exp (λt), where N(t) is the number of bacteria
at time t and λ is the growth rate [10]. For bacteria that are grown in the presence of a sub-lethal concentration
of antibiotic, the growth rate λ is expected to decrease as the antibiotic concentration aex increases. The form of
the growth-inhibition function λ(aex) may depend on the antibiotic [8, 11], the bacterial strain [7, 11], the growth
medium [8] and the presence of other antibiotics [12]. The concentration of antibiotic required to halve the growth
rate, known as the IC50, provides one way to quantify the efficacy of an antibiotic.
Many antibiotics target bacterial ribosomes. Ribosomes are multi-component, molecular machines which carry out
protein synthesis – a function that is crucial for growth. Different ribosome-targeting antibiotics can bind to different
components of the bacterial ribosome and inhibit different steps in protein synthesis [13]. In recent experimental
and theoretical work [8], Greulich et al suggested that ribosome-targeting antibiotics can be classified according to
key features of their growth-inhibition curves λ(aex) and the dependence of their IC50 values on the bacterial growth
medium. Remarkably, this work showed that contrasting experimental observations for the growth-medium dependent
efficacy of different ribosome-targeting antibiotics can be reproduced by a simple mathematical model that takes
account of the molecular processes of antibiotic-ribosome binding and antibiotic transport across the cell boundary,
as well as the physiological processes of cell growth and ribosome synthesis [8]. In the model, the latter processes
are coupled to the state of the cell’s ribosome pool via empirical “growth laws” [14, 15]: experimentally-established
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2mathematical relations that describe how a bacterial cell balances the production of new ribosomes and of other
proteins, depending on its growth rate. Ref. [8] focuses on the response to a fixed (time-invariant) antibiotic
concentration; here we subject the same model to time-dependent antibiotic perturbations.
In a clinical situation, during antibiotic treatment a bacterial infection experiences a time-varying local concen-
tration of antibiotic [11]. Pharmacokinetic curves describe the time-dependent local antibiotic concentration at an
infection site; these curves show a peak as the antibiotic concentration initially increases following ingestion and
transport to the active site and later decreases due to possible metabolism within the body and excretion [11, 16].
Pharmacodynamics attempts to link these curves to the efficacy of antibiotic action [11, 16]. In particular, some
dosing protocols are designed to maximise the peak concentration, whereas others aim to maximise the time at which
the concentration is maintained above a certain threshold, or, alternatively, the area of the curve which is above a
threshold [11]. Importantly, for some antibiotics, activity can persist for some time after the antibiotic is removed:
this is known as the post-antibiotic effect [17, 18] and occurs for a variety of antibiotics including ribosome-targeting
aminoglycosides [18, 19]. The mechanisms behind this effect are unknown but may include slow recovery after
reversible damage to cell structures, slow removal of the antibiotic from its binding site, and the need to synthesize
new enzymes before a bacterium can resume growth [17].
In this paper, we use the mathematical model of ribosome-targeting antibiotics introduced in Ref. [8] to make
dynamical predictions for the response of bacterial growth rate to a time-varying antibiotic concentration. The model
predicts qualitatively different dynamical responses for ribosome-targeting antibiotics that bind to ribosomes with
high affinity and/or are transported into the cell irreversibly (“high-affinity antibiotics”), as opposed to antibiotics
that bind with low affinity and/or are transported reversibly (“low-affinity antibiotics”) . Our results reproduce some
known pharmodynamic phenomena, such as a post-antibiotic effect for high-affinity ribosome-targeting antibiotics.
Our model also predicts new phenomena, including a transient increase in growth rate upon removal of a low-affinity
ribosome-targeting antibiotic. We suggest ways in which these predictions could be tested experimentally and comment
on their potential clinical relevance.
Background: Mathematical model for the action of ribosome-targeting antibiotics
We first provide a brief description of the model which was introduced in Ref. [8]. As illustrated in Figure 1,
the model describes a bacterial cell as homogeneous mixture of ribosomes and antibiotic molecules, which can bind
reversibly to the ribosomes. The variables of the model are the concentrations of bound and unbound ribosomes, rb
and ru respectively, and the concentration of intracellular antibiotic a. The model consists of the following set of
equations for the dynamics of the concentrations:
a˙ = −F (a, ru, rb)− λa+ Pinaex − Pouta, (1)
r˙u = −F (a, ru, rb)− λru + s, (2)
r˙b = F (a, ru, rb)− λrb. (3)
Here, F (a, ru, rb) ≡ kona (ru − rmin) − koffrb describes the antibiotic-ribosome binding / unbinding kinetics. Pin
and Pout are rate constants (or permeabilities) for antibiotic transport into and out of the cell (both assumed to be
linear processes), and aex(t) is the time-varying external antibiotic concentration, which can be controlled in a lab
experiment, or is set by the dosing regime in a clinical scenario. The bacterial growth rate is denoted by λ and the
terms −λa, −λru and −λrb describe dilution of the cell contents by growth. Finally, s is the rate of synthesis of new
ribosomes; s is a function of the state of the system and will be discussed below.
To complete the model, we also need to describe how the growth rate λ and the ribosome synthesis rate s depend
on the state of the system (grey arrows in Fig. 1). To do this, we use the empirically determined “growth laws” of
Scott et al. [14]. The growth rate λ is taken to be linearly related to the concentration of unbound ribosomes ru:
ru = rmin +
λ
κt
. (4)
Relation (4) is based on experimental measurements for bacteria growing exponentially on a range of nutrients, in
the absence of antibiotic [14, 20]; we assume here, as in Ref. [8], that it also holds in the presence of antibiotic [32].
The constant κt = 6.1 × 10−2µM h−1 is the translation rate of the ribosomes and the constant rmin = 19.3µM is
believed to arise from an inactive pool of ribosomes which may be waiting to initiate translation or stalled during
translation [14, 21]. We have implicitly assumed that these inactive ribosomes do not bind antibiotic, through our
3FIG. 1: Schematic illustration of the model. The bacterial cell is modelled as a well-mixed vessel, containing ribosomes (dark
blue) which may be free or bound by antibiotic. Antibiotic molecules (black circles) can be transported into or out of the cell
(pink arrow) and can bind to or dissociate from ribosomes (orange arrow). The model also includes cell growth (green) and
ribosome synthesis (light blue), both of which are coupled to the state of the cell (these couplings are illustrated by the grey
arrows).
definition of the binding function F (a, ru, rb) [33].
The ribosome synthesis rate s can also be deduced from experimental measurements, for bacteria growing exponen-
tially. Ribosome synthesis is regulated such that inhibition of ribosome action by antibiotic causes the cell to increase
ribosome production [22–24]. Measuring the total ribosome content as a function of (decreasing) growth rate upon
addition of a ribosome-targeting antibiotic, Scott et al. observed a linear relation between total ribosome content rtot
and growth rate [14]:
rtot = rmax −∆rλ
(
1
λ0
− 1
(κt∆r)
)
(5)
where rmax = 65.8µM is a universal maximal ribosome concentration, ∆r = rmax − rmin = 46.5µM is the dynamic
range of the active ribosome concentration and λ0 is the bacterial growth rate in the absence of antibiotic. Eq. (5)
states that the total ribosome content increases as growth rate decreases due to ribosome inhibition, but the slope
of this increase depends on how fast the cells were growing before they were inhibited (i.e. on λ0). Fast-growing
cells, in a rich growth medium, increase their ribosome content proportionally less than do slow-growing cells, in a
poor growth medium. Intuitively, fast-growing cells, which have a high ribosome content, already need to devote
close-to-maximal protein production capacity to ribosome production so cannot increase ribosome synthesis further
upon antibiotic challenge. In contrast, slow-growing cells, which have lower ribosome content, have excess protein
production capacity that can be diverted to ribosome synthesis. In our model the total ribosome concentration is
given by rtot = ru + rb. For cells growing exponentially, the contents of the cell are in steady state, and thus the
rate of ribosome synthesis must match the rate of ribosome removal by dilution: s = λrtot. This leads to a quadratic
expression for the synthesis rate s as a function of λ:
s(λ) = λ
[
rmax − λ∆r
(
1
λ0
− 1
(κt∆r)
)]
. (6)
Eqs. (1)-(3) together with (4) and (6) constitute a complete description of the model.
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FIG. 2: Fixed points of Eq. (7), plotted as a function of the external antibiotic concentration aex, for the two parameter
sets given in Table I, corresponding to antibiotics with large and small values of λ∗0. Panel (a) shows results for a low-affinity
antibiotic, with a large value of λ∗0 (Table I). Panel (b) shows results for a high-affinity antibiotic, with a small value of λ
∗
0 (Table
I). The fixed points were obtained numerically in python using sympy.solvers.solve. The external antibiotic concentration is
scaled by the IC50 value calcuated from Eq. (8) and given in Table I.
It is useful to comment on two points regarding the biological interpretation of this model. First, over times
shorter than the bacterial generation time, the model describes an exponentially growing bacterial cell. To see this,
we note that if the cell is growing exponentially, then its volume increases as V˙ = λV . Assuming that molecules of
a particular type are produced at a rate proportional to the volume, we obtain N˙ = gV for the molecule number
N , where g is a production rate constant. The dynamics of the molecular concentration n = N/V is then given by
n˙ = (1/V )N˙ − (N/V 2)V˙ = g − λn, as in Eqs (1)-(3). Second, over times longer than the bacterial generation time,
the model describes the behaviour of a lineage of cells. Bacterial cells undergo periodic division events; however,
these events do not (on average) change the molecular concentrations, because both the molecule number and the
cell volume are (on average) halved. Thus our model effectively describes an experiment in which we follow the
dynamics of the molecular concentrations within an individual bacterial cell as it grows and divides, and in which,
at each division event, we follow only one of the daughter cells.
Returning to the model equations (1)-(3), (4) and (6), it is useful to analyse the stationary points of the system,
for which we set the time derivatives in Eqs (1)-(3) to zero: a˙ = r˙u = r˙b = 0. Using Eq. (4) to eliminate ru in favour
of λ, then using eq. (3) to eliminate rb in Eqs. (1) and (2) leads to two independent relations between a and λ, which
can be solved to eliminate a. This leads finally to a cubic equation for the stationary points of the growth rate λ [34]:
0 = −
(
λ
λ0
)3(
λ0
λ∗0
)2 [(
1 +
κt
kon
)]
+
(
λ
λ0
)2 [(
1 +
κt
kon
)(
λ0
λ∗0
)2
−
(
Pout + koff
2
√
Poutkoff
)(√
κt
kon
)(
λ0
λ∗0
)]
+
(
λ
λ0
)[(
Pout + koff
2
√
Poutkoff
)(√
κt
kon
)(
λ0
λ∗0
)
− aex
2IC∗50
(
λ0
λ∗0
)
− 1
4
]
+
1
4
, (7)
where KD = koff/kon and we have defined the parameter combinations λ
∗
0 = 2
√
PoutκtKD and IC
∗
50 = λ
∗
0∆r/(2Pin).
Eq. (7) is a key result of Ref. [8]. If the effective parameter λ∗0 is large, corresponding to reversible antibiotic
transport and/or low-affinity binding (large values of Pout and/or KD = koff/kon), then Eq. (7) has a single fixed
point for any given value of aex, as illustrated in Figure 2 (a). This corresponds to a smoothly decreasing growth
inhibition curve, as observed experimentally in Ref. [8] for the antibiotics chloramphenicol and tetracycline. In
contrast, if the parameter λ∗0 is small, corresponding to irreversible transport and/or high-affinity binding (small
values of Pout and/or KD = koff/kon), then the model solution has 3 fixed points for values of aex below a critical
threshold, which is a bifurcation point (Figure 2 (b)). The upper and lower fixed points are stable sinks and the
intermediate fixed point is an unstable saddle point of the dynamics. For example, for the parameter set of Figure
2(b), for aex = 0.9×IC50 (below the bifurcation point), the real parts of the eigenvalues of the Jacobean matrix at
the three fixed points are (−1.1× 104,−0.66,−0.90), (−5.7× 103, 0.89,−0.34), (−1.0× 106,−1.0× 10−3,−2.7× 10−5).
Thus, the first and third fixed points are stable (their eigenvalues have all negative real parts) while the second fixed
5TABLE I: Parameter values used in this study to model low and high-affinity ribosome-targeting antibiotics. These values are
chosen to be within the range of the literature values collated in Ref. [8]. The universal parameters are κt = 6.1×10−2µM h−1,
rmin = 19.3µM and rmax = 65.8µM [8, 14]. Except where stated otherwise, we have assumed an antibiotic-free growth rate λ0
of 1h−1.
Parameter Value for low-affinity antibiotic Value for high-affinity antibiotic
Pin 2000h
−1 1h−1
Pout 100h
−1 0.01h−1
kon 1000µM
−1h−1 1000µM−1h−1
koff 10
5h−1 10h−1
λ∗0 = 2
√
Poutκtkoff/kon 49.4h
−1 0.00493h−1
IC∗50 = λ
∗
0(rmax − rmin)/(2Pin) 0.574µM 0.115µM
Predicted IC50 (from Eq. (8)) 1.43µM 11.64µM
point is unstable (it has an eigenvalue with a postive real part). For aex = 1.1×IC50 (above the bifurcation point),
the single fixed point has eigenvalues with all negative real parts (−1.3 × 106,−1.0 × 10−2,−2.2 × 10−5) - i.e. it is
stable. The bifurcation points of the model are discussed in more detail in Appendix A, where it is also argued that
the value a∗ex = ∆rλ0/(4Pin) is a good approximation for the (upper) bifurcation point.
From a practical point of view, for small values of the external antibiotic concentration, we expect to observe
little inhibition of bacterial growth, corresponding to the upper fixed point of the dynamics. However, for antibiotic
concentrations above the bifurcation point, we expect to see drastic growth inhibition, corresponding to the single
(lower) fixed point. This implies a steep, threshold-like growth inhibition curve, as observed experimentally in Ref.
[8] for the aminoglycosides streptomycin and kanamycin [35]. Eq. (7) can also be used to derive a simple expression
for the dependence of the IC50 on λ0:
IC50
IC∗50
=
1
2
[(
1 +
κt
kon
)(
λ0
λ∗0
)
+
(
λ∗0
λ0
)
+
(Pout + koff)√
Poutkoff
√
κt
kon
]
. (8)
Eq. (8) predicts that antibiotic efficacy will increase with nutrient richness (IC50 decreases with λ0) when λ
∗
0
is large, but that efficacy will decrease with nutrient richness (IC50 increases with λ0) when λ
∗
0 is small. These
predictions, which are in agreement with experimental data, were discussed in detail in Ref. [8].
Model predictions for dynamical response to antibiotic
In a clinical context, antibiotic concentrations vary in time. In this paper, we explore the predictions of the
model defined by Eqs (1)-(3), (4) and (6), for the response of bacterial growth rate to a time-dependent exposure to
antibiotic – i.e. we explore the dynamics a(t), ru(t) and rb(t) for a time-varying external antibiotic concentration
aex(t). In most cases (with some exceptions that we discuss below), these equations are not amenable to analytical
solution in the time-varying case. We therefore obtain predictions by integrating the model equations numerically
[36]. We compare results for two sets of parameters, representing antibiotics which are bound and transported with
“low affinity” (high values of Pout/Pin and koff/kon) and with “high affinity” (low values of Pout/Pin and koff/kon).
These parameters, which are chosen to be within the range of literature values for tetracycline and streptomycin
respectively [37], are listed in Table I.
It is important to note that the growth laws which we use in our model, Eqs. (4) and (6), are derived from
experimental measurements on exponentially growing bacteria, for which all intracellular concentrations are in steady
state. In using these constraints to make predictions for dynamical trajectories we assume that the cell adjusts its
rates of growth and ribosome synthesis rapidly in response to changing external conditions, in comparison to the
rate at which the external conditions vary. It is known that the ribosome synthesis rate can adjust within minutes
to changes in nutrient conditions [25]. A typical timescale for synthesis of a protein molecule is ∼1 minute (∼ 1000
amino acids polymerised at a translation rate of ∼ 20 amino acids per second [20]), while a conservative estimate
for the timescale for synthesis of a ribosome is ∼6 minutes (∼ 7500 amino acids in the entire ribosomal complex,
produced at ∼ 20 amino acids per second [20]). Although in this paper we consider for simplicity step-like changes
in antibiotic concentration, the timescale over which antibiotic concentration builds up in the body after an oral dose
6is ∼30 minutes, with a slower decay time due to excretion [11]. The use of the steady-state constraints (4) and (6)
therefore seems reasonable.
Response to a step increase in antibiotic concentration
To analyse the dynamical behaviour of the model, we first consider the response to a sudden, step-like increase in
antibiotic concentration, from zero to a fixed value: aex(t) = 0 for t < t0 and aex(t) = a
final
ex for t > t0. Although
a step-increase in antibiotic concentration is unlikely in a clinical context, it is achievable in laboratory experiments
(e.g. using a morbidostat [26] or microfluidic flow device [27]).
Low-affinity antibiotic
(a) (b)
(c)
Low affinity
FIG. 3: Dynamical trajectories showing growth inhibition after a step increase in antibiotic concentration, for the low-affinity
parameter set (with parameter values as in Table I). (a): Relative growth rate λ(t)/λ0 as a function of time after the step
increase in antibiotic concentration. The final antibiotic concentration afinalex is indicated by the line colour, ranging from
0.4×IC50 (purple) to 1.3×IC50 (red), in steps of 0.1×IC50. (b): Trajectory in the 3-dimensional space of variables a, ru and
rb, for the case of a step increase to a
final
ex = 2×IC50. The initial and final system states are shown by the green and red points
respectively. (c): Flow diagram showing the direction and magnitude of the flow field r˙u, r˙b for a fixed value of a corresponding
to the final point of the trajectory in panel (b), and for aex = 2×IC50. The trajectory from (b) is also shown here, projected
onto the ru, rb plane.
Figure 3 explores the dynamical response of the model to a step increase in antibiotic concentration, for the
low-affinity antibiotic. The model predicts a strikingly non-monotonic response of the bacterial growth rate λ(t)/λ0,
as shown in Figure 3(a): we observe an initial rapid decrease in growth rate, followed by a slower recovery to a
steady-state value that depends on the antibiotic concentration afinalex . This steady-state value corresponds to the
fixed point of the model dynamics (Figure 2(a)). The origin of this non-monotonic response can be understood
by plotting the trajectory of the model in the 3d space of its variables a, ru and rb, as in Figure 3(b). Following
the increase in aex, the intracellular antibiotic concentration a rapidly increases, accompanied by a decrease in the
concentration of unbound ribosomes and an increase in the concentration of bound ribosomes rb. These changes
7are driven by the rapid dynamics of antibiotic transport and binding/unbinding. The later, much slower, recovery
of the growth rate observed in Figure 3(a) corresponds to an increase in both ru and rb in the trajectory of 3(b)
and is associated with the slower dynamics of ribosome synthesis in response to the antibiotic challenge. Thus, the
non-monotonic response of the growth rate predicted by the model is due to the initial, rapid processes of transport
and binding, followed by a slower partial recovery due to increased ribosome synthesis.
The dynamics of the model can also be illustrated in the form of a flow diagram, as in Figure 3(c). Here, the arrows
show the direction of the flow field r˙u, r˙b for a fixed value of a. The trajectory of Figure 3(b) is shown projected
onto this plane. This diagram illustrates clearly the separation of timescales between transport and binding, which
produce a strong flow field towards the centre of the diagram, and ribosome synthesis, which is responsible for the
slower dynamics as the system approaches the stable fixed point.
High-affinity antibiotic
(b)
(c) (d)
(a)
High affinity
FIG. 4: Dynamical trajectories showing growth inhibition after a step increase in antibiotic concentration, for the high-affinity
parameter set (with parameter values as in Table I). (a): Relative growth rate λ(t)/λ0 as a function of time after the step
increase in antibiotic concentration. The final antibiotic concentration afinalex is indicated by the line colour, ranging from
0.4×IC50 (purple) to 1.3×IC50 (red), in steps of 0.1×IC50. (b): Trajectory in the 3-dimensional space of variables a, ru and rb,
for the case of a step increase to afinalex = 0.9×IC50 (black line) and afinalex = 1.1×IC50 (blue line). The initial and final system
states are shown by the green and red points respectively. (c): Flow diagram showing the direction and magnitude of the flow
field r˙u, r˙b for a fixed value of a corresponding to the final point of the black trajectory in panel (b), and for aex = 0.9×IC50.
The trajectory from (b) is also shown here, projected onto the ru, rb plane. (d): Flow diagram showing the flow field r˙u, r˙b for
a fixed value of a = 200µM and for aex = 0.9×IC50.
The model predictions are strikingly different for the high-affinity antibiotic (Figure 4). The bacterial growth
rate (Figure 4 (a)) is predicted to decrease smoothly and monotonically for low antibiotic concentrations afinalex , as
it approaches the upper fixed point in Figure 2(b). However, for antibiotic concentrations afinalex that are above the
bifurcation point in Figure 2(b) the model predicts instead a decline in growth rate to a state in which there is
essentially no growth. The timescale of this approach to the non-growing steady state can be very long (of the order
of days) for antibiotic concentrations close to the bifurcation point.
8(b)(a)
Low affinity High affinity
FIG. 5: Model predictions for the time required to reach 99% growth inhibition λ/λ0 = 0.01, following a step increase in
antibiotic concentration. The inhibition time is plotted as a function of the external antibiotic concentration (note that the
time is measured in minutes in (a) but in hours in (b)). Panel (a) shows results for the low-affinity antibiotic; panel (b) shows
results for the high-affinity antibiotic (using parameters as in Table I); here the numerical solution of the model is shown by
the solid line while the crosses show the analytical prediction based on the adiabatic approximation, described in Appendix B.
For antibiotic concentrations lower than those plotted here, the dynamical trajectory of λ/λ0 always stays above 0.01.
Plotting the dynamics of the model in the 3d space of its variables, as in Figure 4(b), illustrates the very different
nature of its trajectories for values of afinalex below and above the bifurcation point. If a
final
ex is below the bifurcation
point, as for the black trajectory (for afinalex = 0.9×IC50), the dynamics approaches a fixed point which is close to
the initial state, and in which the intracellular antibiotic concentration is small. This corresponds to the upper
stable fixed point in Figure 2(b). However, if afinalex is above the bifurcation point, as for the blue trajectory (for
afinalex = 1.1×IC50), the dynamics instead approaches a very different state, with a far higher intracellular antibiotic
concentration and with ru close to rmin: this corresponds to the lower fixed point in Figure 2(b), with essentially no
growth.
The flow diagrams of Figure 4(c) and (d) illustrate the two stable fixed points of the model dynamics for values
of aex below the bifurcation point. These diagrams show the flow field r˙u, r˙b for aex = 0.9×IC50, for two different
values of the intracellular antibiotic concentration a. In Figure 4(c), the flow field is shown for a = 0.016µM, which
corresponds to the final point of the black trajectory in Figure 4(b) (this trajectory is also shown, projected onto the
a = 0.016µM plane). The model has a stable fixed point for values of ru and rb which are close to the starting point
of the trajectory (i.e. the system state in the absence of antibiotic). The second stable fixed point is evident in Figure
4(d), which shows the flow field for a = 200µM. This fixed point occurs at a much smaller value of ru (ru ≈ rmin)
and a higher value of rb. Interestingly, as for the low-affinity case (Figure 3(c)), the flow diagrams of Figure 4 show a
separation of timescales between the rapid dynamics of transport and binding and the slower dynamics of ribosome
synthesis. However the separation is less extreme than for the low-affinity case (since Pin, Pout and koff are all smaller)
– this may explain why the approach to the stable state is monotonic rather than non-monotonic for our high-affinity
parameter set.
Time to full inhibition
From a practical point of view, one may be interested in the time taken to achieve full growth inhibition following
a high-concentration antibiotic dose. Because the variables in our model are continuous, the growth rate never
completely reaches zero, but as a proxy for full inhibition we measure the time taken to achieve 99% inhibition, i.e.
to reduce the growth rate to 1% of its antibiotic-free value: λ/λ0 = 0.01. Although this is an arbitrary threshold, we
note that in a clinical situation a drastic reduction in bacterial population density is expected to lead to elimination
of an infection, due to the action of the immune system [28]. In our model, 99% inhibition only occurs for high
concentrations of antibiotic; for lower concentrations the system instead reaches a steady state with a growth rate
greater than 0.01× λ0 (as shown in Figures 3(a) and 4(a)).
Figure 5 shows the time to reach λ = 0.01 × λ0, as a function of the antibiotic concentration, for the low-affinity
9and high-affinity antibiotics. As expected, higher antibiotic concentrations lead to more rapid growth inhibition.
For the low-affinity antibiotic (Figure 5(a)), a high concentration is needed to achieve 99% inhibition (∼ 35×IC50),
but for these concentrations, 99% inhibition is achieved very rapidly, on a timescale of minutes. The inhibition time
decreases smoothly as the antibiotic concentration increases. This is consistent with the inhibition trajectories shown
in Figure 3(a), which show a rapid initial inhibition of growth, followed by a slower partial recovery to the steady
state. For the high-affinity antibiotic (Figure 5(b)), 99% inhibition is achieved for much lower concentrations of
antibiotic, just above the IC50, but the timescale for inhibition is much longer, of the order of hours for concentrations
close to the IC50. This is consistent with the inhibition trajectories of Figure 4(a), which show very long timescales
for inhibition for external antibiotic concentrations close to the bifurcation point of the model dynamics. As we
discuss in Appendix B (and illustrate in Figure 9), this very slow inhibition occurs because of a “bottleneck” effect,
in which dynamical trajectories slow down as they pass close to the location where the two fixed points have merged.
For the high-affinity antibiotic, it is possible to obtain an analytical prediction for the time to achieve 99% inhibition,
by making an adiabatic approximation for the dynamics of the intracellular antibiotic concentration a(t). This
calculation is presented in detail in Appendix B; briefly, we assume that the dynamics of a(t) are fast compared to
those of the other variables, and set a˙ = 0 in Eqs (1)-(3). This reduces the model to a set of dynamical equations for
ru and rb, and setting koff = 0 (for an irreversible antibiotic) decouples these equations, allowing one to solve for ru,
and hence for the growth rate λ(t) via the constraint (4). Figure 5(b) shows that the resulting analytical prediction
for the inhibition time (crosses) is in good agreement with the numerical results (solid line).
Response to a step pulse of antibiotic
In a clinical situation, antibiotic treatment has a finite duration. The local antibiotic concentration at the infection
site increases after a dose is given and later decreases due to removal of the antibiotic from the body (the pharmocoki-
netic curve [11]). To mimic such a scenario, we investigate the response of the model to pulses of antibiotic of finite
duration. We obtain predictions for the dynamics of the bacterial growth rate during and after the dose, for low- and
high-affinity antibiotics, and for different dose durations and intensities. For simplicity, we first consider a step pulse
of antibiotic of intensity S that is maintained for a fixed time T , as illustrated in Figure 6(a); later we also consider
a continuously varying dose function. We compare results for a fixed total antibiotic dose (duration × intensity) –
i.e. we compare the effect of a short, high-intensity dose with that of a long, low-intensity dose. Specifically, we fix
S×T = 4×IC50. Although this choice is arbitrary, we find qualitatively similar results for other values of the total dose.
Low-affinity antibiotic: growth-rate overshoot following antibiotic removal
Figure 6(b) shows the model predictions for the bacterial growth rate, during and after a step-like pulse of a
low-affinity antibiotic. The colours indicate doses of varying duration (as shown by the bars). During the dose,
bacterial growth is suppressed, to a degree that depends on the intensity of the dose (the short, high intensity dose
shown by the blue line causes a greater degree of growth inhibition than the long, low intensity dose shown by the
red line). Interestingly, the model also predicts a “growth rate overshoot” phenomenon: a peak in λ(t) after the
antibiotic dose ends, implying a transient increase in growth rate above the antibiotic-free steady-state value λ0.
This overshoot is predicted to be significant, with the growth rate increasing to more than 1.5× λ0 for intermediate
dose durations. The overshoot occurs because, in our model, ribosome synthesis is upregulated during exposure to
the antibiotic (s is larger, according to Eq. (6)), such that the total ribosome concentration is higher than it would
be in the absence of antibiotic. Once the external antibiotic is removed, intracellular antibiotic dissociates rapidly
from bound ribosomes, since koff  λ0, so that the free ribosome pool becomes transiently larger than it would have
been in the absence of antibiotic. In our model, this produces a transient increase in growth rate. The magnitude
of the effect is greatest at intermediate antibiotic dose duration; this is because for very short antibiotic pulses,
the bacterium does not have time to increase its ribosome pool significantly before the pulse ends, while for very
long pulses the antibiotic concentration (pulse intensity) is not high enough to produce a significant upregulation of
ribosome concentration. Consistent with this explanation, when we repeat our simulations keeping the dose intensity
fixed (i.e. increasing total dose as the duration increases), we find that the maximal overshoot occurs for the longest
dose duration.
Upregulation of ribosome synthesis upon exposure to antibiotic is a growth medium-dependent phenomenon: for
bacteria growing in a poor medium (with a small drug-free growth rate λ0), the relative increase of the ribosome
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FIG. 6: Growth inhibition in response to a transient step-like dose of antibiotic. (a): Illustration of the dosing protocol:
antibiotic concentration is switched suddenly to a value S at the start of the dose, and is switched back to zero after a time
T . The total dose S × T is fixed at 4×IC50. (b) Growth-rate trajectories for the low-affinity antibiotic (with parameters as in
Table I). The coloured lines represent doses of different duration and intensity (keeping the total dose fixed at 4×IC50). The
colour bars show the duration of the dose. (c) As in panel (b), but for the high-affinity antibiotic (with parameters as in Table
I). (d) Schematic illustration of hysteresis in the model for the high-affinity antibiotic. The response to a low-intensity pulse of
antibiotic is shown by the red line: upon addition of antibiotic the system tracks the upper stable fixed point and reverses its
trajectory when the antibiotic is removed. The response to a high-intensity pulse is shown by the blue lines: upon addition of
antibiotic the system transitions to the lower stable fixed point, and it tracks the lower fixed point when antibiotic is removed.
(e) Time taken to recover from a step dose of antibiotic, as a function of the duration of the dose. The solid line shows results
for the low-affinity antibiotic, the symbols show results for the high-affinity antibiotic. Here, “recovery” is defined to mean that
the growth rate λ returns to a value 0.9 × λ0, having previously fallen below this threshold. The recovery time is defined as
the total time during which the growth rate is suppressed below 0.9× λ0.
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synthesis rate is larger than for bacteria growing on rich medium (with a large λ0) [14]. This growth medium
dependence is captured by the λ0-dependence of the synthesis rate s in our model (Eq. (6)). We therefore expect
that the magnitude of the growth-rate overshoot predicted by the model will be medium-dependent, with a larger
overshoot for small values of λ0, i.e. for bacteria growing on poor medium, because these bacteria upregulate
ribosome synthesis more strongly during the antibiotic pulse and therefore have a greater excess of ribosomes after
the pulse. Indeed, upon repeating our calculations for a range of values of λ0, we observe a strong λ0-dependence
of the magnitude of the overshoot. For example, for a dose of duration σ = 7h (orange curve in Fig. 6(b)),
the growth rate at the peak of the overshoot is predicted to be λ/λ0 = 2.3, 1.7, 1.3, for drug-free growth rates of
λ0 = 0.5, 1.0, 1.5h
−1 respectively.
High-affinity antibiotic: post-antibiotic growth suppression and hysteresis
Figure 6(c) shows equivalent predictions for the growth-rate response to a step pulse of high-affinity antibiotic.
Here we observe a different phenomenon: the qualitative nature of the response is highly intensity-dependent. For
long-duration, low-intensity doses the growth rate is suppressed during the dose but recovers quickly when the
antibiotic is removed (red-green curves in Figure 6(c)). However, for shorter, high intensity doses, the model shows a
significant post-antibiotic effect: the growth rate decreases almost to zero during the dose and does not recover until
many hours after the dose has ended (blue curves in Figure 6(c)). This phenomenon arises from hysteresis in the
model. When antibiotic is added, the fixed points of the model move along the aex axis in Figure 2(b). As illustrated
schematically in Figure 6(d), for a low-intensity antibiotic dose, the system tracks the upper stable fixed point and
reverses its trajectory when the antibiotic is removed (red line in Figure 6(d)). This corresponds to the red-green
trajectories in Figure 6(c). However, for a high-intensity antibiotic dose, the system is pushed past the bifurcation
point in Figure 2(b), forcing it to transition to the lower stable fixed point in which the growth rate is close to
zero. When the antibiotic is removed, the system moves back along the lower line of fixed points, before eventually
transitioning back to the upper fixed point (blue lines in Figure 6(d)). The timescale over which this eventual
recovery happens is controlled by the antibiotic-ribosome dissociation rate constant koff , which is small for the
high-affinity antibiotic. Although we always see eventual recovery of the bacterial growth rate in our simulations, in
a clinical setting we expect that other factors, such as immune response, would lead to elimination of the infection [28].
Optimal dosing strategy differs for low and high-affinity antibiotics
In a clinical setting, antibiotic dosing protocols target different features of the pharmacokinetic curve: some are
designed to maximise the peak antibiotic concentration, while others aim to maximise the time the concentration is
above a threshold, or the area of the curve above the threshold [11, 29]. Although our simulated step-like dosing
protocol (Figure 6(a)) is simplistic, we do see clear differences in optimal dosing strategy for low-affinity and high-
affinity antibiotics. These differences are illustrated in Figure 6(e), where we plot the time required to recover from
a step-like antibiotic dose, as a function of the duration of the dose (and hence its inverse intensity, as shown on
the upper horizontal axis). Here, we define time to recovery as the time taken for the growth rate λ to recover
to 90% of its antibiotic-free steady state value λ0, having previously falled to below this value. For the low-affinity
antibiotic (Figure 6(e), solid line), the recovery time is proportional to dose duration: this is consistent with the growth
inhibition trajectory (Figure 6(b)), in which growth is suppressed during the dose and recovers rapidly afterwards.
Therefore, for ribosome-targeting antibiotics which bind with low affinity and/or are transported reversibly, the model
suggests that an optimal protocol would maximise the time over which the dose is maintained above a threshold. In
contrast, for the high-affinity antibiotic (Figure 6(e), symbols), the model predicts that the recovery time increases
dramatically, to many times longer than the dose, when the dose intensity exceeds a well-defined threshold (i.e. for
shorter dose durations in our simulations). This is also consistent with the growth inhibition trajectories of 6(c).
Thus our model suggests that for ribosome-targeting antibiotics which bind with high affinity and/or are transported
irreversibly, it may be more important to maximise the peak concentration of the pharmacokinetic curve than the
duration of the dose. This prediction is consistent with the observation that aminoglycoside antibiotics can show
significant post-antibiotic effects [17–19, 29, 30].
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FIG. 7: Growth inhibition in response to a transient dose of antibiotic with a Gaussian profile. (a): Illustration of the
dosing protocol. The total dose, which is given by
√
2piAσ, is fixed at 4×IC50. (b) Results for the low-affinity antibiotic,
with parameters as in Table I. The coloured lines represent doses of different duration and intensity, from σ = 0.4h (blue) to
σ = 1.1h (red), keeping the total dose fixed). The colour bars show the approximate duration, 2σ, of the dose. (c) Results
for the high-affinity antibiotic, with parameters as in Table I. Colours are as in (b). (d) Time taken to recover from a step
dose of antibiotic, as a function of the duration of the dose. “Recovery” is defined as an increase in λ(t) to a value 0.9λ0,
having previously been below this threshold. The recovery time is defined as the total time during which the growth rate
is suppressed below 0.9 × λ0. The solid line shows results for the low-affinity antibiotic, the symbols show results for the
high-affinity antibiotic. For the high-affinity case, the growth rate eventually recovers to its pre-dose value, on a timescale that
is longer than shown in the plot.
Response to a smooth pulse of antibiotic
Real pharmacokinetic curves are of course smooth rather than step-like. To test the generality of our results,
we also simulated the dynamical response to a smooth pulse of antibiotic, represented by a Gaussian function
aex(t) = A exp [−(t− tmax)2/(2σ2)], as illustrated in Figure 7(a). We varied the peak dose intensity A and the dose
duration parameter σ, keeping the total dose, which is given approximately by
√
2piAσ, fixed at 4×IC50. For all plots
shown in Fig. 7 we fix tmax = 6h.
Figure 7(b) shows results for the low-affinity antibiotic. As for the step pulse, the bacterial growth rate is
suppressed during the Gaussian antibiotic pulse, to an extent that depends on pulse intensity (the longer, less intense
pulse shown by the red curve produces longer duration but weaker growth suppression than the shorter, more intense
pulse shown by the blue curve). The model also predicts the same growth-rate overshooting phenomenon following
the Gaussian antibiotic pulse which we observed for the step pulse. As for the step pulse, the magnitude of this
overshoot increases as the drug-free growth rate λ0 decreases (data not shown).
The response to a Gaussian pulse of a high-affinity antibiotic (Figure 7(c)) is also qualitatively similar to that
for the step pulse (Figure 6(c)). As for the step pulse, for pulses of intensity below a threshold value, the growth
rate recovers quickly following the antibiotic dose. However for pulses with intensity above the threshold, there is
a post-antibiotic effect, in which growth suppression persists for long times after the antibiotic has been removed
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(recovery happens over timescales that are longer than those shown in Figure 6(c)).
Figure 7(d) shows the predicted recovery time after a Gaussian pulse of antibiotic, defined as the time to reach
λ = 0.9λ0, as in Figure 6(d) for the step-like pulse. For the low-affinity antibiotic (solid line in Figure 7(d)), the time
to recovery increases with the dose duration. This supports our prediction that for the low-affinity antibiotic, dose
duration is the key determinant of treatment efficacy. For the high-affinity antibiotic (symbols in Figure 7(d)), the
time to recovery shows qualitatively similar behaviour to that for the step-like pulse (compare to Figure 6(d)), in
that the time to recovery is very long for short, intense pulses, but decreases dramatically for pulses with intensity
below a threshold. The more complex shape of the plot for low-intensity pulses, compared to the results for the step
pulse (Figure 6(d)) is due to the shape of the Gaussian pulse; for values of σ above ∼ 4.3h, the growth rate no longer
decreases below 0.9λ0.
Taken together, our results for the Gaussian and step-like pulses of antibiotic show that the phenomena predicted
by our model: (i) duration-dependent efficacy for ribosome-targeting antibiotics which bind with low affinity and/or
are transported reversibly, (ii) growth-rate overshoot for these “low-affinity” antibiotics, (iii) peak intensity-dependent
efficacy for ribosome-targeting antibiotics that bind with high affinity and/or are transported irreversibly and (iv)
post-antibiotic effect for these “high-affinity” antibiotics, are all independent of the details of the form of the antibiotic
dosage protocol.
Discussion
In this paper, we have studied the dynamical response of the bacterial growth rate to sustained and transient
antibiotic treatment, for ribosome-targeting antibiotics. The model that we have used is simple: it includes only
antibiotic-ribosome binding, antibiotic transport, growth, and ribosome synthesis, with the latter two processes
being dependent on the state of the system. In previous work [8], this model has been shown to predict qualitatively
different steady-state behaviour for two classes of ribosome-targeting antibiotics: “low-affinity” antibiotics which
bind to ribosomes with low affinity and/or are transported reversibly across the cell boundary, and “high-affinity”
antibiotics which bind with high affinity and/or are transported irreversibly.
Here, we have shown that these two classes of antibiotics also show qualitatively different dynamical responses to
antibiotic treatment. Low-affinity antibiotics show a non-monotonic response, with a rapid decrease in growth rate
upon exposure to antibiotic, followed by a slower partial recovery mediated by up-regulation of ribosome synthesis.
Up-regulation of ribosome synthesis during exposure also means that these antibiotics are predicted to show a
striking growth rate overshoot upon removal of the antibiotic. In contrast, high-affinity antibiotics show a strongly
concentration-dependent response: upon antibiotic exposure, the growth rate decreases very little if the antibiotic
concentration is below a threshold given by the bifurcation point of the model dynamics, but it decreases almost to
zero upon exposure to antibiotic concentrations above the threshold. Close to the threshold concentration the time
taken to reach this maximal inhibition can, however, be very long: this behaviour can be understood by the fact
that the dynamical trajectories of the model slow down as they pass close to the location where the two fixed points
have merged. Furthermore, the model predicts a pronounced post-antibiotic suppression of growth upon removal of
a high-affinity antibiotic, for concentrations above the threshold – a phenomenon that results from hysteresis in the
model dynamics.
Are these predictions realistic? Of course many factors have not been included in the model. For example,
we have assumed throughout that growth rate is determined by the active ribosome abundance, via Eq. (4).
Although this relation is well-established for steady-state growth, other factors may come into play during transient
growth-rate change. In particular, the growth rate may become limited by the supply of amino acids rather than
by the abundance of free ribosomes. This might reduce or eliminate the growth-rate overshoot predicted by our
model for the low-affinity antibiotics. During an antibiotic pulse, when translation is inhibited, the total ribosome
abundance is close to maximal (rtot ≈ rmax in Eq. (5)). According to the proteome partitioning model, this increased
production of ribosomes comes at the expense of producing metabolic enzymes necessary for amino acid supply
[14, 24]. Thus, when the antibiotic is removed and ribosomes are released, there is likely to be a transient period
when the rate of growth is limited by amino acid supply, before metabolic enzymes are re-synthesized to restore
the balance between amino acid influx and the demands of translating ribosomes [24]. Our model also neglects
any other effects of the antibiotics on bacterial physiology: for example, aminoglycosides may increase membrane
permeability through the production of misfolded protein [31]. In addition, we do not model bacterial killing, either
directly by antibiotic action, or indirectly via the body’s immune system [28]. Inclusion of these killing effects
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in the model would be likely to prevent the long-time recovery dynamics predicted here for the high-affinity antibiotics.
To conclusively assess the realism of the predictions reported here, one would need experimental tests. Several
recently-developed bacterial growth techniques make such tests feasible. At the level of bulk cultures, continuous
culture devices have been developed that allow measurement of growth rate during time-dependent antibiotic
exposure [26]. At the level of individual cells, microfluidic devices in which the antibiotic concentration can be
changed rapidly as growth is monitored in a microscope are also now possible [27]. The latter would be an especially
interesting approach since the bistability which is manifested in our model for high-affinity antibiotics might lead to
heterogeneous responses to antibiotic exposure among cells in a population.
If confirmed experimentally, the phenomena reported here would be of considerable clinical significance. In
particular, our results make a clear prediction for the optimal pharmacodynamic strategy: for low-affinity drugs
one should aim to maximise the time of exposure, while for high-affinity drugs, one should aim to maximise the
peak dosage. Moreover, the latter are predicted to show a pronounced post-antibiotic effect, meaning that they can
be effective for much longer than the actual duration of exposure. Post-antibiotic effects are a widely recognised,
but poorly understood, pharmacodynamic phenomenon, and occur for various antibiotics including aminoglycosides
[17–19]. Our work suggests that models that integrate molecular mechanism with bacterial cell physiology can be a
useful tool for understanding such clinically relevant growth inhibition phenomena and thus, potentially, for helping
to improve clinical practice.
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Appendix A: Bifurcation points of the model
As we show in Fig. 2, the model described by Eqs. (1) – (3) may have different numbers of stationary points
(stable and unstable fixed points), depending on the parameter values. Changes in the number and character
of the fixed points of the model occur at critical parameter values, and are known as bifurcation points. Fig. 8
illustrates these bifurcation points in more detail. Here we use a parameter set intermediate between the low and
high-affinity cases studied in the rest of the paper: Pin = 1h
−1, Pout = 1 h−1, kon = 1000µM−1h−1. We vary
the parameter koff and plot the fixed points of the model as a function of aexPin. Fig. 8(a) shows results with
koff = 1000 h
−1, for which there is only a single fixed point. In contrast, for a smaller value of koff = 100 h−1,
as shown in Fig. 8(b), for some values of aexPin the model has one fixed point (which is stable), and for other
values of aexPin there are three fixed points, two of which are stable and one unstable. The regime in which
there are three fixed points is bistable (shaded) and is bounded by two bifurcation points, labelled a∗ex,low and
a∗ex,high in Fig. 8(b), where the number of fixed points changes. The upper bifurcation point a
∗
ex,high is associ-
ated with a steep decrease in the growth rate λ, since at this bifurcation point the upper stable fixed point is lost
and λ drops to the lower fixed point. This critical value a∗ex,high is very close to (though not exactly equal to) the IC50.
The bifurcation points can be calculated by noting that the fixed points of the model dynamics are given
by the roots of Eq. (7). The number of roots — and thus the number of fixed points – is determined by the
discriminant of Eq. (7): if the discriminant is positive there are three roots, otherwise, there is only one root.
Thus the zeros of the discriminant mark the bifurcation points. Since Eq. (7) is a cubic equation in λ, it may
be written as aλ3 + bλ2 + cλ + d, with discriminant ∆ = b2 − 4ac3 − 4b3d − 27a2d2 + 18abcd. The zeros of
the discriminant can be computed numerically. Fig. 8(c) shows the results of such a computation: here the
bifurcation points a∗ex,low and a
∗
ex,high are plotted as a function of koff . Since the discriminant itself is cubic in aex it
may have either one or three zeros; those at positive aex correspond to a
∗
ex,low and a
∗
ex,high [38]. For low values of
koff there are two bifurcation points as in Fig. 8(b), while for high values of koff there is no bifurcation, as in Fig. 8(a).
We can also obtain an analytical estimate for the upper bifurcation point aex = a
∗
ex,high, which corresponds to the
antibiotic concentration at which the model predicts a threshold drop in growth rate. To this end, we rewrite Eq. (7)
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FIG. 8: Illustration of the bifurcation points of the model. (a) Growth rate as a function of aexPin for koff = 1000 h
−1,
Pin = 1h
−1, Pout = 1 h−1 and kon = 1000µM−1h−1. For this parameter set the system has one fixed point. (b) Growth rate
as a function of aexPin for koff = 100 h
−1, Pin = 1h−1, Pout = 1 h−1 and kon = 1000µM−1h−1. Here, the system has regimes
with one fixed point and a bistable regime with three fixed points (shaded area) – two of which are stable (solid lines) and one
unstable (dashed blue line). The bistable regime is bounded by the critical values a∗ex,low and a
∗
ex,high. (c) The critical points
a∗ex,low and a
∗
ex,high, computed from the discriminant of Eq. (7) as detailed in the text and plotted as function of koff . The
bistable regime is shaded. The blue dashed line marks the analytical estimate ∆rλ0/4 for the upper critical point a
∗
ex,high,
which is valid for kon  κt and Poutkoff . aexPinλ/∆r. Note that since Eq. (7) is symmetric under exchange of koff and Pout,
a∗exPin as a function of Pout would look exactly the same for koff = 1 h
−1.
in the form
0 =
λ
koffPout
(
aexPin
∆r
+ λ− 1
λ0
λ2
)
(9)
+
(
κt
kon
)[
1 +
(
1
Pout
+
1
koff
− 1
λ0
)
λ−
(
1
Poutλ0
+
1
koffλ0
− 1
Poutkoff
)
λ2 − 1
Poutkoffλ0
λ3
]
,
(note that we have multiplied Eq. 7 by a factor of 4). Interestingly, this equation depends only on the combination
aexPin rather than on aex and Pin independently. This is why we have used the parameter combination aexPin in Fig.
8; it also implies that the critical values a∗ex scale as a
∗
ex ∼ 1/Pin. For kon  κt, and koffPout not too large, the second
term in Eq. (9) can be neglected and we arrive at the quadratic equation
0 =
aexPin
∆r
+ λ+
1
λ0
λ2. (10)
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The zero of the discriminant is then at
a∗exPin =
∆rλ0
4
. (11)
Setting rmin = 19.3µM, rmax = 65.8µM, and λ0 = 1 h
−1, as in Table I, this gives a∗exPin = 11.625µM h
−1, shown in
Fig. 8(c) as the blue dashed line. Fig. 8(c) shows that for small values of koff this provides a very good estimate for
the upper bifurcation point a∗ex,high. Thus, a
∗
ex = 11.625µM h
−1/Pin is a good estimate for the threshold antibiotic
concentration and the IC50 for high-affinity antibiotics. Remarkably, this approximation does not explicitly depend
on Pout, koff or kon. For large values of koff or Pout, however, this approximation does not hold anymore, since the
prefactor 1/(koffPout) in Eq. (9) decreases the importance of the first term relative to the second term.
Appendix B: Analytical calculation of inhibition time for a high-affinity antibiotic using the adiabatic
approximation
Incorporating expression (6) for the ribosome synthesis rate into the dynamical equations (1)-(3), our model can
be expressed as:
a˙ = −λa− kon(ru − rmin)a+ Pinaex − Pouta+ koffrb (12)
r˙u = −λru − kon(ru − rmin)a+ λ(rmax − λc) + koffrb (13)
r˙b = −λrb + kon(ru − rmin)a− koffrb (14)
where ∆ = rmax−rmin, c ≡ ∆r( 1λ0 − 1κt∆r ) and λ is a function of ru via Eq. (4). Making the adiabatic approximation,
i.e. setting a˙ = 0, and using Eq. (4) to eliminate ru, Eq. (12) gives
a =
Pinaex + koffrb
Pout + λ(1 +
kon
κt
)
. (15)
Substituting Eq. (15) into Eqs. (13) and (14) and using Eq. (4) to change variables from ru to λ, we obtain
λ˙ = −λ2(1 + cκt)− konλ(Pinaex + koffrb)
Pout + λ(1 +
kon
κt
)
+ koffκtrb + ∆rλκt (16)
and
r˙b = −λrb + konλ/κt Pinaex + koffrb
Pout + λ(1 +
kon
κt
)
− koffrb. (17)
In Eq. (16), we then make the approximation that λ(1+kon/κt) Pout [39]. Since we are dealing with a high-affinity
antibiotic, we also set koff = 0. This allows us to express the model as an equation in one variable only (the growth
rate λ(t)):
λ˙ = −λ2(1 + cκt)− konPinaex
(1 + konκt )
+ ∆rλκt. (18)
Returning to Eq. (18), we can integrate the trajectory λ(t) to predict the time Tc required for λ to reach a predefined
threshold λc:
Tc =
∫ λ=λc
λ=λ0
dλ
−λ2(1 + cκt)− konPinaex(1+ konκt ) + ∆rλκt
. (19)
This integral can be solved using the substitution u = ∆rκt/2−(1+cκt)λ√
(1+cκt)C−(∆rκt)2/4
, where we have defined C = konPinaex
1+ konκt
.
This gives the following result:
Tc =
1√
(1 + cκt)C − (∆rκt)2/4
∫ u(λc)
u(λ0)
du
1
1 + u2
(20)
=
1√
(1 + cκt)C − (∆rκt)2/4
(
arctan
(
κt∆r/2− (1 + cκt)λc√
(1 + cκt)C − (∆rκt)2/4
)
− arctan
(
κt∆r/2− (1 + cκt)λ0√
(1 + cκt)C − (∆rκt)2/4
))
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FIG. 9: Rate of change of growth rate λ˙, plotted as a function of λ, as given by the adiabatic approximation, Eq. (18).
Panel (a) shows results for aex = 0.95×IC50 (just below the bifurcation point of Figure 2(b)), while panel (b) shows results for
aex = 1.05×IC50 (just above the bifurcation point).
Setting λc = 0.01λ0 in Eq. (20) leads to the results shown as the solid curve in Figure 5. Note that this integration
is only valid if (∆rκt)
2 − 4(1 + cκt)C < 0. Otherwise, the denominator becomes zero and Tc diverges. This would be
the case if the system is at the upper stable fixed point of the dynamics, such that the growth rate is not significantly
decreased upon exposure to the antibiotic.
This analysis also allows us to understand the origin of the very slow inhibition dynamics for the high-affinity
antibiotic, for values of aex just above the bifurcation point, as shown in Figure 4(a). Figure 9 shows the rate of
change of the growth rate, λ˙, plotted as a function of λ, as predicted by Eq. (18), for the high-affinity parameter set.
Figure 9(a) shows results for aex = 0.95×IC50 (just below the bifurcation point): the fixed points correspond to zeroes
of λ˙ and the stable one is indicated by the arrow (there is of course also another stable fixed point at very small λ,
but this is lost in the quadratic approximation of Eq. (18)). Figure 9(b) shows equivalent results for a slightly higher
antibiotic concentration, aex = 1.05×IC50, just above the bifurcation point. Here the fixed points are lost, but the
rate of change of λ still comes close to zero, implying that the speed of inhibition by the antibiotic will be very slow.
This slow dynamics close to the bifurcation point can be thought of as a “bottleneck” in the inhibition trajectory.
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